Stock Taper
SCREENER COMPARE ANY 2 STOCKS
FRNM
FREENOME, INC. COMMON STOCK
NASDAQ
$13.81
▲ UP 2.22% (0.30)

KEY STATISTICS

Market Cap$112.65 M
52w High$14.47
52w Low$9.95
Dividend Yield—
Frequency—
P/E—
Volume735.07K
Shares Out.8.16M

COMPANY

LEADERSHIP

Aaron Elliott
CHIEF EXECUTIVE
Aaron Elliott

ABOUT

SECTOR
Healthcare
WENT PUBLIC
July 21, 2026
METHOD OF GOING PUBLIC
SPAC
FULL TIME EMPLOYEES
363

PRICE TARGET

Target High$21.00
Target Low$17.00
Target Median$17.50
Target Consensus$18.25

UPCOMING EARNINGS

DateDec 2, 2026
DayWednesday
Rev. Est.$84.94M
DEC
2
WED

PRICE

$13.81 ▲ UP 2.22% (+$0.30)
$13.40$13.60$13.80$14.009:30 AM10:35 AM11:40 AM12:44 PM1:49 PM2:54 PM3:59 PM13.81

About Freenome, Inc. Common stock

https://www.freenome.com ↗

Perceptive Capital Solutions Corp. is a blank check company founded in 2024 in New York, aiming to merge, acquire, or reorganize with one or more businesses.

INDUSTRY

Biotechnology

A PRODUCT FREENOME, INC. COMMON STOCK IS KNOWN FOR

SimpleScreen™ CRC
SimpleScreen™ CRC

Freenome's first commercial-stage blood-based screening test for early colorectal cancer detection, utilizing multiomics and AI, is under FDA review.

COMPETITORS

COMPETITOR
GH COMPARE
GRAL COMPARE
IMDX COMPARE

ETFS HOLDING THIS STOCK

ETFS HOLDING
2
LISTED HERE
2
RANKED BY POSITION SIZE
ARKG
0.48% · 673.9K
TNXT
0.10% · 1.4K

INSIDER TRADES

★
OTHER: FORMER DIRECTOR
Waksal Harlan
Sale · 30.0K shares
2026-07-20
★
OTHER: FORMER DIRECTOR
Waksal Harlan
Purchase · 30.0K shares
2026-07-20
★
OFFICER: CHIEF PRODUCT OFFICER
Ennis Riley Charles
— · 118.5K shares
2026-07-20
★
DIRECTOR
VAN OORT DOUGLAS M
— · 32.1K shares
2026-07-20